These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 25735323)
1. Impact of age, tumor size, lymph node metastasis, stage, receptor status and menopausal status on overall survival of breast cancer patients in Pakistan. Mahmood H; Faheem M; Mahmood S; Sadiq M; Irfan J Asian Pac J Cancer Prev; 2015; 16(3):1019-24. PubMed ID: 25735323 [TBL] [Abstract][Full Text] [Related]
2. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer. Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737 [TBL] [Abstract][Full Text] [Related]
3. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival. Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770 [TBL] [Abstract][Full Text] [Related]
4. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis. Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532 [TBL] [Abstract][Full Text] [Related]
5. The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis. Sujarittanakarn S; Himakhun W; Worasawate W; Prasert W Asian Pac J Cancer Prev; 2020 Jun; 21(6):1559-1565. PubMed ID: 32592349 [TBL] [Abstract][Full Text] [Related]
6. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan. Sharif MA; Mamoon N; Mushtaq S; Khadim MT J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India. Ambroise M; Ghosh M; Mallikarjuna VS; Kurian A Asian Pac J Cancer Prev; 2011; 12(3):625-9. PubMed ID: 21627355 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab. Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy]. Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696 [TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression]. Fan Y; Guan Y; Zhao WH; Li Q; Xu BH Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993 [TBL] [Abstract][Full Text] [Related]
11. Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients. Haroon S; Hashmi AA; Khurshid A; Kanpurwala MA; Mujtuba S; Malik B; Faridi N Asian Pac J Cancer Prev; 2013; 14(7):4353-8. PubMed ID: 23992002 [TBL] [Abstract][Full Text] [Related]
12. Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up. Buta M; Džodić R; Đurišić I; Marković I; Vujasinović T; Markićević M; Nikolić-Vukosavljević D Tumour Biol; 2015 Sep; 36(10):8193-200. PubMed ID: 25994573 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement. Sofi GN; Sofi JN; Nadeem R; Shiekh RY; Khan FA; Sofi AA; Bhat HA; Bhat RA Asian Pac J Cancer Prev; 2012; 13(10):5047-52. PubMed ID: 23244108 [TBL] [Abstract][Full Text] [Related]
14. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand. Shahi KS; Bhandari G; Singh A J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737 [TBL] [Abstract][Full Text] [Related]
15. The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer. Tang D; Xu S; Zhang Q; Zhao W Med Oncol; 2012 Jun; 29(2):526-33. PubMed ID: 21519872 [TBL] [Abstract][Full Text] [Related]
16. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients. van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438 [TBL] [Abstract][Full Text] [Related]
17. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes. He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605 [TBL] [Abstract][Full Text] [Related]
18. Her-2 prognostic value in very early-stage breast cancer: a single-institution retrospective analysis. Sanpaolo P; Barbieri V; Pedicini P; Fusco V Med Oncol; 2012 Jun; 29(2):459-65. PubMed ID: 21359639 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases]. Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002 [TBL] [Abstract][Full Text] [Related]
20. [Clinical features and prognosis analysis of different breast cancer molecular subtypes]. Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]